Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children.

Inagaki, J; Nagatoshi, Y; Hatano, M; Isomura, N; Sakiyama, M; Okamura, J

Inagaki, J; Nagatoshi, Y; Hatano, M; Isomura, N; Sakiyama, M; Okamura, J.

Affiliation

Inagaki J; Section of Pediatrics, National Kyusyu Cancer Center, Fukuoka, Japan.

Bone Marrow Transplant ; 41(6): 571-7, 2008 Mar.

Article in En | MEDLINE | ID: mdl-18026150

Subject(s)

Graft vs Host Disease/drug therapy; Immunosuppressive Agents/administration & dosage; Methotrexate/administration & dosage; Acute Disease; Adolescent; Child; Child, Preschool; Chronic Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents/adverse effects; Male; Methotrexate/adverse effects; Prednisone/administration & dosage; Retrospective Studies; Time Factors; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Graft vs Host Disease / Immunosuppressive Agents Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Child, preschool / Female / Humans / Male Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2008 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links